🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-525059-23-00
Terminated Phase I

The effect of losartan on cephalexin

2025-525059-23-00 · tracked via the Priya Life Science EU tracker
Sponsor
Varsinais-Suomen hyvinvointialue
Sponsor type
Hospital/Clinic/Other health care facility
Therapeutic area
Not possible to specify
Decision date
26/02/2026
Enrollment target
12
Sites
Finland

Condition studied

healthy volunteers

Eligibility

Age group
18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-525059-23-00 on CTIS ↗ ← All trials in the EU